Grant: Project Grant
Université de Montréal
$100,000.00
Examining chemical modulation of kinesin-13 activities: From mechanism to validation
EF 2016-17
Résumé
Microtubules (MTs) are protein polymers that form a cable-like network of transport super-highway to move important cargoes around inside a cell. One of these cargoes is our chromosomes, the genetic material that makes us what we are. It turns out that these cables need to grow and shrink all the time to perform their functions such as capturing and transporting chromosomes, especially when cells are dividing. A clinically proven strategy to stop cancer cell proliferation is to perturb the growing and shrinking dynamics of MT polymers. In fact, MT-targeting drugs are among the most successful chemotherapeutic agents currently used in the clinics. However, their success is hindered by adverse side effects and the development of drug resistance in cancer patients. To address these shortcomings, Dr. Kwok's lab attempts to further this proven approach by achieving the same therapeutic benefits through an alternative route - by targeting the protein enzymes that control the MT polymers. Using a high-throughput screening approach, his lab has already identified chemical agents that modulate these MT modifying enzymes. Importantly, these agents not only suppress cancer cell growth, but seem to spare non-cancer cells. However, the precise molecular mechanism how these molecules work is still not known. In the proposed research, Dr. Kwok's team aims to use modern cutting-edge technologies to understand the following: 1) How these chemical agents affect the MT-regulating enzymes at the molecular level; 2) how this in turn affects cancer cell proliferation; 3) how to expand the chemical diversity of this new class of potential chemotherapeutics. Their ultimate goal is to validate this new strategy in order to help develop the next generation anti-cancer drugs with fewer side effects.
Programme
Project Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
351812
Name
Kwok Benjamin H
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Project Grant Competition
Projecttitle
Examining chemical modulation of kinesin-13 activities: From mechanism to validation
Programtype2
Operating Grants
Orgnameinp2
Université de Montréal
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Cancer; Cell Biology; Chemical Biology; Drug Development; Fluorescent Light Microscopy; High-Throughput Screen; Kinesin Motor Proteins; Live Cell Imaging; Microtubules; Protein Biochemistry
Abstract
Microtubules (MTs) are protein polymers that form a cable-like network of transport super-highway to move important cargoes around inside a cell. One of these cargoes is our chromosomes, the genetic material that makes us what we are. It turns out that these cables need to grow and shrink all the time to perform their functions such as capturing and transporting chromosomes, especially when cells are dividing. A clinically proven strategy to stop cancer cell proliferation is to perturb the growing and shrinking dynamics of MT polymers. In fact, MT-targeting drugs are among the most successful chemotherapeutic agents currently used in the clinics. However, their success is hindered by adverse side effects and the development of drug resistance in cancer patients. To address these shortcomings, Dr. Kwok's lab attempts to further this proven approach by achieving the same therapeutic benefits through an alternative route - by targeting the protein enzymes that control the MT polymers. Using a high-throughput screening approach, his lab has already identified chemical agents that modulate these MT modifying enzymes. Importantly, these agents not only suppress cancer cell growth, but seem to spare non-cancer cells. However, the precise molecular mechanism how these molecules work is still not known. In the proposed research, Dr. Kwok's team aims to use modern cutting-edge technologies to understand the following: 1) How these chemical agents affect the MT-regulating enzymes at the molecular level; 2) how this in turn affects cancer cell proliferation; 3) how to expand the chemical diversity of this new class of potential chemotherapeutics. Their ultimate goal is to validate this new strategy in order to help develop the next generation anti-cancer drugs with fewer side effects.
Competitiondate
201604
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kwok, Benjamin H
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~